Skip to main content

Free Content CSF hypocretin measures in patients with obstructive sleep apnea

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library


The majority of patients with narcolepsy-cataplexy were reported to have very low cerebrospinal fluid (CSF) hypocretin-1 (orexin-A) levels. The hypocretin-1 levels of secondary excessive daytime sleepiness (EDS) disorders are not known. In this study, we found that CSF hypocretin levels in the patients with obstructive sleep apnea syndrome were within the control range. The low hypocretin levels seem to reflect only the presence of cataplexy and DR2 positive in narcoleptics but not EDS itself.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: cerebrospinal fluid; hypocretin; narcolepsy; obstructive sleep apnea; orexin

Document Type: Research Article

Affiliations: 1: Department of Neuropsychiatry, Akita University School of Medicine, Akita 2: Department of Neuropsychiatry, Juntendo University School of Medicine, Tokyo 3: Department of Neurology, Kansai-Denryoku Hospital, Osaka 4: Department of Neuropsychiatry, Asahikawa Medical College, Asahikawa, Japan

Publication date: 2003-12-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more